RRRahul Rathakrishnan

Rahul Rathakrishnan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rahul Rathakrishnan has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Association between haemorrhagic transformation in acute ischaemic strokes and incidence of post-stroke epilepsy: A systematic review and meta-analysis

    by Nicholas Goh, Karthikeyan Saravanan, Mya Thee Char Tin Oo, Evan Michael Neo Ren Jie, Rahul Rathakrishnan, Mingxue Jing, Jennifer Hung, Ching-Hui Sia, Benjamin Yq Tan, Hui Shi Lim, et al.

  • Clinical outcomes of cryptogenic new onset refractory status epilepticus (NORSE) in a tertiary hospital in Singapore: a case series

    by Yihui Goh, Christopher Yan Kit Chua, Tiffany Li Jia Lee, Derek Soon, Yao Feng Chong, Rahul Rathakrishnan

    Background New Onset Refractory Status Epilepticus (NORSE) is a neurological emergency with high mortality. Cryptogenic NORSE (cNORSE) is defined by a lack of an identifiable structural, toxic or metabolic etiology despite extensive workup. Survivors often develop significant long-term neurological sequelae and drug-resistant epilepsy. However, studies have shown that despite prolonged hospitalization, a significant proportion of cNORSE patients can achieve favourable functional outcomes. Methods A retrospective review of adult cNORSE patients between July 2019 and July 2023 in a tertiary hospital in Singapore was performed. Results Thirteen patients with cNORSE were identified. Median age at presentation was 32.2 [IQR: 23.9–44.1] years and 6 (46.2%) of the patients were male. Eight (61.5%) patients fulfilled criteria for Febrile Infection-Related Epilepsy Syndrome (FIRES). Eight (61.5%) patients had abnormal index brain MRIs. The median duration of ICU stay was 37.0 [22.8–41.5] days. The total number of anti-seizure medications (ASMs) and anesthetics used was 6 [5–7] and 3 [2–4] respectively. All patients received immunotherapy and the time to immunotherapy initiation from SE onset was 2 [1–3] days. 4 (30.8%) patients demised during inpatient stay. Of 9 surviving patients, the median MRS on discharge was 4 [3–5]. MRS at 3 month and 1 year follow ups was 2 [1–5] and 1.0 [0.8-5.0] respectively. Conclusions This retrospective study characterizes a cryptogenic NORSE cohort in a tertiary hospital in Singapore. Cryptogenic NORSE is associated with significant morbidity and mortality; however, long term outcomes may still be favourable in patients with initially severe illness and protracted ICU stay.


  • Bridging the Gap: Tailoring an Approach to Treatment in Febrile Infection‐Related Epilepsy Syndrome

    by Yihui Goh, Sen Hee Tay, Leonard Leong Litt Yeo, Rahul Rathakrishnan

    Cytokine profiling prior to immunotherapy is increasingly prevalent in Febrile infection-related epilepsy syndrome (FIRES). In this case, an 18-year-old boy presented with first-onset seizure after a nonspecific febrile illness. He developed super refractory status epilepticus requiring multiple anti-seizure medications and general anesthetic infusions. He was treated with pulsed methylprednisolone, plasma exchange and ketogenic diet. Contrast-enhanced MRI brain revealed post-ictal changes. EEG showed multifocal ictal runs and generalized periodic epileptiform discharges. Cerebrospinal fluid analysis, autoantibody testing and malignancy screen were unremarkable. Genetic testing revealed variants of uncertain significance (VUS) in the CNKSR2 and OPN1LW genes. Initial serum and CSF cytokine analyses performed on days 6 and 21 revealed that IL-6, IL-1RA, MCP1, MIP1β and IFNγ were elevated predominantly in the CNS, a profile consistent with cytokine release syndrome. Tofacitinib was initially trialed on day 30 of admission. There was no clinical improvement and IL-6 continued to rise. Tocilizumab was given on day 51 with significant clinical and electrographic response. Anakinra was subsequently trialed from days 99 to 103, as clinical ictal activity re-emerged on weaning anesthetics, but stopped due to poor response. Serial cytokine profiles showed improvement after 7 doses of tocilizumab. There was corresponding improved seizure control. This case illustrates how personalized immunomonitoring may be helpful in cases of FIRES, where proinflammatory cytokines are postulated to act in epileptogenesis. There is an emerging role for cytokine profiling and close collaboration with immunologists for the treatment of FIRES. The use of tocilizumab may be considered in FIRES patients with upregulated IL-6.


  • Improving automated diagnosis of epilepsy from EEGs beyond IEDs

    by Prasanth Thangavel, John Thomas, Nishant Sinha, Wei Yan Peh, Rajamanickam Yuvaraj, Sydney S Cash, Rima Chaudhari, Sagar Karia, Jin Jing, Rahul Rathakrishnan, et al.

    Objective. Clinical diagnosis of epilepsy relies partially on identifying interictal epileptiform discharges (IEDs) in scalp electroencephalograms (EEGs). This process is expert-biased, tedious, and can delay the diagnosis procedure. Beyond automatically detecting IEDs, there are far fewer studies on automated methods to differentiate epileptic EEGs (potentially without IEDs) from normal EEGs. In addition, the diagnosis of epilepsy based on a single EEG tends to be low. Consequently, there is a strong need for automated systems for EEG interpretation. Traditionally, epilepsy diagnosis relies heavily on IEDs. However, since not all epileptic EEGs exhibit IEDs, it is essential to explore IED-independent EEG measures for epilepsy diagnosis. The main objective is to develop an automated system for detecting epileptic EEGs, both with or without IEDs. In order to detect epileptic EEGs without IEDs, it is crucial to include EEG features in the algorithm that are not directly related to IEDs. Approach. In this study, we explore the background characteristics of interictal EEG for automated and more reliable diagnosis of epilepsy. Specifically, we investigate features based on univariate temporal measures (UTMs), spectral, wavelet, Stockwell, connectivity, and graph metrics of EEGs, besides patient-related information (age and vigilance state). The evaluation is performed on a sizeable cohort of routine scalp EEGs (685 epileptic EEGs and 1229 normal EEGs) from five centers across Singapore, USA, and India. Main results. In comparison with the current literature, we obtained an improved Leave-One-Subject-Out (LOSO) cross-validation (CV) area under the curve (AUC) of 0.871 (Balanced Accuracy (BAC) of 80.9%) with a combination of three features (IED rate, and Daubechies and Morlet wavelets) for the classification of EEGs with IEDs vs. normal EEGs. The IED-independent feature UTM achieved a LOSO CV AUC of 0.809 (BAC of 74.4%). The inclusion of IED-independent features also helps to improve the EEG-level classification of epileptic EEGs with and without IEDs vs. normal EEGs, achieving an AUC of 0.822 (BAC of 77.6%) compared to 0.688 (BAC of 59.6%) for classification only based on the IED rate. Specifically, the addition of IED-independent features improved the BAC by 21% in detecting epileptic EEGs that do not contain IEDs. Significance. These results pave the way towards automated detection of epilepsy. We are one of the first to analyze epileptic EEGs without IEDs, thereby opening up an underexplored option in epilepsy diagnosis.


  • Open Access

    A Meta-Analysis of the Rates of Suicide Ideation, Attempts and Deaths in People with Epilepsy

    by Nicholas Abraham, P. Buvanaswari, Rahul Rathakrishnan, Bach X. Tran, Giang Vu. Thu, Long H. Nguyen, Cyrus S. Ho, Roger C. Ho

    This meta-analysis aimed to evaluate the association between epilepsy and suicide. We systematically searched PubMed, PsycINFO, Embase and Web of Science for studies that reported the prevalence of suicidality in the form of suicide ideation, attempts and deaths among people with epilepsy (PWE). Studies were included if they reported the numbers of patients who died by suicide and concurrently suffered from epilepsy, assessed suicide ideation, or studied suicide attempts in PWE by validated instruments or diagnostic interviews. We used the random effects model to calculate the pooled odds ratios (OR) and standard mean differences (SMDs). We performed subgroup analyses. Seven case-control studies were included in the comparison of rates of suicide attempts between PWE and controls, with a total of 821,594 participants. Our analyses demonstrated a positive association between epilepsy and suicide attempts (pooled OR = 3.25, 95% confidence interval (CI): 2.69–3.92, p < 0.001), indicating that PWE have an elevated risk of suicide. The pooled prevalence for suicide ideation (24 studies) and suicide attempts (18 studies) were 23.2% (95% CI: 0.176–0.301) and 7.4% (95% CI: 0.031–0.169) respectively. The pooled rate of death due to suicide (10 studies) was 0.5% (95% CI: 0.002–0.016). Meta-regression showed that mean age and proportion of male gender were significant moderators for prevalence of suicide attempts and death due to suicide in PWE. Young PWE could be triggered by relationship problems and male PWE might use more lethal methods to attempt suicide. This meta-analysis provides the most up-to-date information on the prevalence of suicide among people with epilepsy and guidance on strategies to improve current psychiatric services provided for this population.


  • Validation of Serial Alberta Stroke Program Early CT Score as an Outcome Predictor in Thrombolyzed Stroke Patients

    by Wan-Yee Kong, Benjamin Y.Q. Tan, Nicholas J.H. Ngiam, Deborah Y.C. Tan, Christine H. Yuan, Staffan Holmin, Tommy Andersson, Erik Lundström, Hock Luen Teoh, Bernard P.L. Chan, et al.


  • Intravenous Thrombolysis for Acute Ischemic Stroke due to Cervical Internal Carotid Artery Occlusion

    by Leonard L.L. Yeo, Wan Yee Kong, Prakash Paliwal, Hock L. Teoh, Raymond C. Seet, Derek Soon, Rahul Rathakrishnan, Venetia Ong, Tsong-Hai Lee, Ho-Fai Wong, et al.


  • IV thrombolysis for acute cervical Internal Carotid Artery Occlusion (P6.237)

    by Wan Yee Kong, Benjamin Tan, Hock Luen Teoh, Raymond Seet, Bernard Chan, Rahul Rathakrishnan, Derek Soon, Vijay Sharma, Leonard Yeo